Replies to post #375689 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

Don't know. Don't care. Their CEO recently has said that he is stepping down after the Aduhelm disaster.

Biogen Inc (BIIB.O) said on Tuesday that chief executive Michel Vounatsos will step down and that the company is pulling back on selling its controversial Alzheimer's drug Aduhelm, in what appears to be a final blow to its prospect of becoming a big seller.

But then we have the same calls for MIssling.

Perhaps this PR is the Biogen's CEO last ditch attempt to save his job.